| Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice. |
2016 |
Eritja N; Arjo G; Santacana M; Gatius S; Arcal L; Serrano JC; Pamplona R; Dolcet X; Piñol C; Christou P; Matias-Guiu X; Portero-Otin M. |
Article d'investigació |
| Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma, but not myeloid malignancies. |
2016 |
Mirantes C, Dosil MA, Hills D, Yang J, Eritja N, Santacana M, Gatius S, Vilardell F, Medvinsky A, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model. |
2015 |
Eritja N, Santacana M, Maiques O, Gonzalez-Tallada X, Dolcet X, Matias-Guiu X: |
Article d'investigació |
| Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells |
2014 |
Eritja N, Domingo M, Dosil MA, Mirantes C, Santacana M, Valls J, Llombart-Cussac A, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas |
2014 |
Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M |
Article d'investigació |
| Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometriaT cells and drives PTEN loss-induced hyperplasic growth |
2013 |
Eritja, N.; Mirantes, C.; Llobet, D.; Yeramian, A.; Bergadà, L.; Dosil, M.A.; Domingo, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture |
2013 |
Chen N, Eritja N, Lock R, Debnath J. |
Article d'investigació |
| Three-dimensional epithelial cultures: a tool to model cancer development and progression |
2013 |
Eritja N, Dolcet X, Matias-Guiu X. |
Review |
| Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells |
2013 |
Bergadà, L.; Sorolla, A.; Yeramian, A.; Eritja, N.; Mirantes, C.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance |
2012 |
Eritja N, Mirantes C, Llobet D, Masip G, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. |
2011 |
Llobet, D.; Eritja, N.; Domingo, M.; Bergada, L.; Mirantes, C.; Santacana, M.; Pallares, J.; Macià, A.; Yeramian, A.; Encinas, M.; Moreno Bueno, G.; Palacios, J.; Lewis, R.E.; Matias Guiu, X.; Dolcet, |
Article d'investigació |
| Nuclear factor-kappa B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1 alpha independent manner |
2011 |
Yeramian, A.; Santacana, M.; Sorolla, A.; Llobet, D.; Encinas, M.; Velasco, A.; Bahi, N.; Eritja, N.; Domingo, M.; Oliva, E.; Dolcet, X.; Matias Guiu, X. |
Article d'investigació |
| The multikinase inhibitor sorafenib induces apoptosis and sensitizes endometrial cancer cells to TRAIL by different mechanisms |
2010 |
Llobet, D.; Eritja, N.; Encinas, M.; Yeramian, A.; Pallares, J.; Sorolla, A.; Santacana, M.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| A novel 3D culture system of polarized epithelial cells to study endometrial carcinogenesis |
2010 |
Eritja N; Llobet D; Domingo M; Yeramian A; Matias-Guiu X; Dolcet X. |
Article d'investigació |
| CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation. |
2009 |
Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X. |
Article d'investigació |
| A review of the aplications of tissue microarray technology in understanding the molecular features of endometrial carcinoma |
2009 |
Pallarés, J.; Santacana, M.; Puente, S.; López, S.; Yeramian, A.; Eritja, N.; Sorolla, A.; Llobet, D.; Dolcet, X.; Matias Guiu, X. |
Review |
| Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutical view points |
2009 |
Llobet, D.; Pallares, J.; Yeramian, A.; Santacana, M.; Eritja, N.; Velasco, A.; Dolcet, X.; Matias Guiu, X. |
Review |
| CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells |
2008 |
Llobet, D.; Eritja, N.; Encinas. M.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. |
2008 |
Pallarés J, Velasco A, Eritja N, Santacana M, Dolcet X, Cuatracasas M, Palomar-Asenjo V, Catasús Ll, Prat J, Matias-Guiu X. |
Article d'investigació |
| Antioxidants block proteasome inhibitor function in endometrial carcinoma cells |
2008 |
Llobet, D.; Eritja, N.; Encinas, M.; Sorolla, A.; Yeramian, A.; Schoenenberger, J.A.; Llombart Cussac, A.; Martí, R.M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Loss of heterozygosity in endometrial carcinoma |
2008 |
Velasco A; Pallarés J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X |
Review |
| Nuclear factor-kappa B activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma |
2008 |
Gallel, P.; Pallares, J.; Dolcet, X.; Llobet, D.; Eritja, N.; Santacana, M.; Yeramian, A.; Palomar Asenjo, V.; Lagarda, H.; Mauricio, D.; Encinas, M.; Matias Guiu, X. |
Article d'investigació |
